Kanawha Capital Management LLC Pfizer Inc Transaction History

Kanawha Capital Management LLC

  • $1.29 Billion
  • Q3 2024

A detailed history of Kanawha Capital Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, Kanawha Capital Management LLC holds 279,327 shares of PFE stock, worth $7.67 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares
279,327
Previous 270,352 3.32%
Holding current value
$7.67 Million
Previous $7.56 Million 6.86%
% of portfolio
0.62%
Previous 0.62%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024
BUY
$27.7 - $31.39 $248,607 - $281,725
8,975 Added 3.32%
279,327 $8.08 Million
Q2 2024

Jul 25, 2024
BUY
$25.26 - $29.6 $234,918 - $275,280
9,300 Added 3.56%
270,352 $7.56 Million
Q1 2024

Apr 29, 2024
BUY
$25.89 - $29.73 $987,082 - $1.13 Million
38,126 Added 17.1%
261,052 $7.24 Million
Q4 2023

Jan 29, 2024
SELL
$26.13 - $33.94 $630,725 - $819,243
-24,138 Reduced 9.77%
222,926 $6.42 Million
Q3 2023

Oct 26, 2023
BUY
$32.09 - $37.51 $84,332 - $98,576
2,628 Added 1.08%
247,064 $8.2 Million
Q2 2023

Jul 28, 2023
BUY
$36.12 - $41.79 $56,058 - $64,858
1,552 Added 0.64%
244,436 $8.97 Million
Q1 2023

May 08, 2023
BUY
$39.39 - $51.28 $183,360 - $238,708
4,655 Added 1.95%
242,884 $9.91 Million
Q4 2022

Feb 01, 2023
SELL
$41.75 - $54.5 $172,218 - $224,812
-4,125 Reduced 1.7%
238,229 $12.2 Million
Q3 2022

Oct 31, 2022
SELL
$43.76 - $53.42 $197,576 - $241,191
-4,515 Reduced 1.83%
242,354 $10.6 Million
Q2 2022

Jul 27, 2022
BUY
$46.53 - $55.17 $31,407 - $37,239
675 Added 0.27%
246,869 $12.9 Million
Q1 2022

Apr 26, 2022
BUY
$45.75 - $56.69 $382,058 - $473,418
8,351 Added 3.51%
246,194 $12.7 Million
Q4 2021

Jan 31, 2022
BUY
$41.32 - $61.25 $48,633 - $72,091
1,177 Added 0.5%
237,843 $14 Million
Q3 2021

Oct 28, 2021
BUY
$39.25 - $50.42 $41,605 - $53,445
1,060 Added 0.45%
236,666 $10.2 Million
Q2 2021

Jul 22, 2021
BUY
$35.91 - $40.68 $81,515 - $92,343
2,270 Added 0.97%
235,606 $9.23 Million
Q1 2021

Apr 26, 2021
BUY
$33.49 - $37.77 $190,290 - $214,609
5,682 Added 2.5%
233,336 $8.45 Million
Q4 2020

Feb 01, 2021
BUY
$33.47 - $42.56 $50,138 - $63,754
1,498 Added 0.66%
227,654 $8.38 Million
Q3 2020

Oct 29, 2020
BUY
$31.75 - $37.25 $108,553 - $127,357
3,419 Added 1.53%
226,156 $8.3 Million
Q2 2020

Aug 04, 2020
BUY
$30.12 - $36.54 $59,848 - $72,604
1,987 Added 0.9%
222,737 $7.28 Million
Q1 2020

May 04, 2020
BUY
$27.03 - $38.62 $198,156 - $283,123
7,331 Added 3.44%
220,750 $7.21 Million
Q4 2019

Jan 31, 2020
BUY
$32.92 - $37.36 $571,952 - $649,092
17,374 Added 8.86%
213,419 $8.36 Million
Q3 2019

Nov 01, 2019
BUY
$32.49 - $42.13 $234,122 - $303,588
7,206 Added 3.82%
196,045 $7.04 Million
Q2 2019

Jul 30, 2019
BUY
$36.98 - $41.52 $202,465 - $227,322
5,475 Added 2.99%
188,839 $8.18 Million
Q1 2019

Apr 23, 2019
SELL
$37.5 - $41.2 $114,075 - $125,330
-3,042 Reduced 1.63%
183,364 $7.79 Million
Q4 2018

Jan 23, 2019
BUY
$38.47 - $43.86 $56,820 - $64,781
1,477 Added 0.8%
186,406 $8.14 Million
Q3 2018

Oct 25, 2018
BUY
$34.47 - $41.81 $10,858 - $13,170
315 Added 0.17%
184,929 $8.15 Million
Q2 2018

Jul 27, 2018
SELL
$32.98 - $35.16 $49,766 - $53,056
-1,509 Reduced 0.81%
184,614 $6.7 Million
Q1 2018

Apr 19, 2018
BUY
$31.91 - $37.02 $102,558 - $118,982
3,214 Added 1.76%
186,123 $6.61 Million
Q4 2017

Jan 26, 2018
BUY
$33.26 - $35.29 $70,910 - $75,238
2,132 Added 1.18%
182,909 $6.63 Million
Q3 2017

Oct 26, 2017
BUY
$31.0 - $34.15 $5.6 Million - $6.17 Million
180,777
180,777 $6.45 Million

Others Institutions Holding PFE

# of Institutions
3,253
Shares Held
3.72B
Call Options Held
73.5M
Put Options Held
108M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Kanawha Capital Management LLC Portfolio

Follow Kanawha Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kanawha Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kanawha Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email